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Abstract
Purpose To perform a systematic review of the health-
related quality of life (HRQoL) and economic burdens of
anorexia nervosa (AN), bulimia nervosa (BN), and binge
eating disorder (BED).
Methods A systematic literature search of English-lan-
guage studies was performed in Medline, Embase, Psy-
cINFO, PsycARTICLES, Academic Search Complete,
CINAHL Plus, Business Source Premier, and Cochrane
Library. Cost data were converted to 2014 Euro.
Results Sixty-nine studies were included. Data on
HRQoL were reported in 41 studies (18 for AN, 17 for BN,
and 18 for BED), on healthcare utilization in 20 studies (14
for AN, 12 for BN, and 8 for BED), and on healthcare costs
in 17 studies (9 for AN, 11 for BN, and only 2 for BED).
Patients’ HRQoL was significantly worse with AN, BN,
and BED compared with healthy populations. AN, BN, and
BED were associated with a high rate of hospitalization,
outpatient care, and emergency department visits. How-
ever, patients rarely received specific treatment for their
eating disorder. The annual healthcare costs for AN, BN,
and BED were €2993 to €55,270, €888 to €18,823, and
€1762 to €2902, respectively.
Conclusions AN, BN, and BED have a serious impact on
patient’s HRQoL and are also associated with increased
healthcare utilization and healthcare costs. The burden of
BED should be examined separately from that of BN. The
limited evidence suggests that further research is warranted
to better understand the differences in long-term HRQoL
and economic burdens of AN, BN, and BED.
Keywords Eating disorders  Quality of life  Cost of
illness  Anorexia nervosa  Bulimia nervosa  Binge eating
disorder
Introduction
Anorexia nervosa (AN), bulimia nervosa (BN), and binge
eating disorder (BED) are prevalent psychiatric disorders
that are characterized by different symptoms. Based on
mixed gender surveys, the lifetime prevalence of AN is
estimated to be approximately 0.5–0.6 %, that of BN
0.5–1 %, and that of BED 1.1–2.3 % [1–3]. The onset of the
majority of eating disorders (EDs) occurs between the ages
of 10–20 years; however, in contrast to AN and BN, BED
often occurs in older cohorts [3]. AN, BN, and BED are
associated with numerous physical (e.g., diabetes, hyper-
tension, ulcers) and mental health conditions (e.g., anxiety
disorder, depression) [2, 4–7]. Furthermore, patients with
EDs have significantly elevated mortality rates compared
with the standard population norms as well as higher suicide
rates [8, 9].
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Despite the major public health burden of AN, BN, and
BED, there is lack of evidence on the differences in the
health-related quality of life (HRQoL) and economic
impact of different EDs [10, 11]. The objective of this
study is to perform a systematic review of the published
literature on the HRQoL and economic burdens of AN,
BN, and BED. To our knowledge, no systematic review has
been published on this topic to date.
Materials and methods
This systematic review was based on an extensive literature
search on the epidemiology, and HRQoL and economic
burdens of EDs (i.e., AN, BN, BED, and eating disorders
not otherwise specified [EDNOS]). The literature search
was conducted in 2013 using Medline, Embase (via Sco-
pus), PsycINFO, PsycARTICLES, Academic Search
Complete, CINAHL Plus, Business Source Premier (via
Ebsco Host), and Cochrane Library. The search terms are
detailed in Online Resource 1. The search results were
processed in two steps: first, the titles and abstracts of all
the articles were screened; next, all the potentially relevant
articles were analyzed in full text. The references of the
included articles were screened for additional eligible
studies. The literature screening was conducted by two
independent reviewers and disagreements were resolved by
the principal researcher.
The reasons for exclusion were as follows for the arti-
cles: (1) was not written in English; (2) was not published
in a peer-reviewed journal; (3) was an editorial, letter, case
report, or review; (4) was not specific to AN, BN, or BED;
and (5) had an objective other than studying the HRQoL
and/or economic burden (i.e., healthcare resource utiliza-
tion, healthcare costs, and societal costs) of AN, BN, or
BED. This review includes only publications in which AN,
BN, and BED samples were clearly separated.
The following information was extracted from each
included study: (1) the first author and year of publica-
tion; (2) the country; (3) the study design; (4) the study
year; (5) the included ED(s); (6) the diagnostic criteria for
EDs; (7) the characteristics of the study sample [sample
size, % of female, age, and body mass index (BMI)]; (8)
data on the HRQoL burden (HRQoL instrument, main
findings); (9) data on healthcare utilization (i.e., resource
use data on primary care, outpatient services, and inpa-
tient care including emergency services); and (10) data on
healthcare costs (i.e., the costs generated by health service
utilization and medication use) and/or societal costs (i.e.,
costs related to the loss of productivity and symptom-
related food costs) (perspective of the analysis, year of
pricing, resource use and/or cost categories, and resource
use and/or cost data).
To compare costs across studies, the costs were
extrapolated to annual costs per case and inflated to year
2014 values, using country-specific GDP (gross domestic
product) deflators. The costs were converted into United
States (US) dollars where necessary, using purchasing
power parities and then exchanged to euro (€) using the
average annual US dollar/euro exchange rate for 2014
(0.7536). If the year of pricing was not referenced, the
midpoint in the observation period was assumed to be the
base year; if no observation period was reported, the year
of publication was adopted as the base year.
Results
The systematic literature search resulted in 7211 hits. The
screening of titles and abstracts identified 540 potentially
eligible articles. Finally, 69 studies were included in this
review. Two records were identified through a hand search
of the references of the relevant articles. A flow diagram of
the systematic literature search, based on the Preferred
Reporting Items for Systematic Reviews and Meta-Anal-
yses (PRISMA) template [12], is presented in Fig. 1. The
characteristics of the reviewed studies are detailed in
Online Resource 2.
Health-related quality of life burden
Data on the HRQoL of AN, BN, BED, and rela-
tives/caregivers of ED patients were reported in 41 studies:
18 for AN [13–30], 17 for BN [13–15, 17, 20–25, 27, 29–
34], 18 for BED [17, 21, 22, 24, 35–48], and 5 for the
relatives/caregivers of ED patients [49–53]. Seventeen
types of HRQoL instruments were applied in the included
studies. The Medical Outcome Study Short Forms (i.e.,
Short Form 36 [SF-36] and Short Form 12 [SF-12]) were
the most commonly used (n = 19) HRQoL questionnaires
and were administered alone [16, 17, 19, 21, 24–27, 32, 33,
36, 38, 40, 42, 43] or in combination with other HRQoL
questionnaires [13, 22, 23, 37] (Table 1). The reported
HRQoL data are summarized in Online Resource 3.
Patients with AN, BN, and BED were shown to have
significantly lower HRQoL than the general population
[18, 34, 37, 39, 40, 43]. Many of the included studies
investigated the differences between the HRQoL impact of
AN, BN, and BED/EDNOS. One of these studies evaluated
patients with AN or BN and compared them to healthy
subjects [20]. Both ED groups showed significantly more
impairment than controls in the health domains of the
Nottingham Health Profile (NHP), and the AN patients had
significantly reduced mobility compared with the BN
patients and the healthy controls. Three studies compared
patients with AN, BN, or BED. One of them showed no
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differences in HRQoL, but demonstrated a significant
relationship between HRQoL and the severity of eating
symptomatology [24]. Another study found a more
heterogeneous picture using the SF-36 [17]. Patients with
BN or BED had lower scores than the non-ED subjects on
the SF-36 Mental Component Summary (MCS) (mean
[SD]: 43.76 [9.35], 40.83 [9.00] and 49.83 [16.47],
respectively), but no differences were found on the SF-36
Physical Component Summary (PCS) between the ED
groups and the non-ED group (mean [SD]: 43.40 [9.02] for
AN, 47.20 [9.47] for BN, 46.31 [9.12] for BED, and 48.08
[16.67] for non-ED subjects). Regarding the various
domains, the BN patients had lower scores on the Role
Emotional, Social Functioning, Mental Health, Vitality,
and General Health scales than the non-ED subjects, and
the BED patients had lower scores on the Role Emotional,
Mental Health, and Vitality scales than the non-ED sub-
jects [17]. Mond et al. [22] presented similarly heteroge-
neous findings: significantly lower MCS scores in the BN
and purging AN groups compared to the restrictive AN
group (the MCS mean [SD] scores were: 27.60 [9.44] vs.
26.96 [7.44] vs. 38.38 [11.05], respectively), and signifi-
cantly lower World Health Organization Brief Quality of
Life Assessment (WHOQOL-BREF) Social Relationship
Scale (QoLS) scores in the BED and purging AN groups
compared with the restrictive AN group (mean [SD]: 2.20
[0.98] vs. 2.58 [1.06] vs. 3.58 [1.01], respectively). Rie
et al. [25] could not show any HRQoL difference on
comparing AN, BN, and EDNOS groups to each other, but
all of the ED patients had significantly poorer HRQoL than
the normal reference group. Focusing on EDNOS [27], no
differences were detected between the EDNOS and BN
groups on the SF-36 General Health and Healthy Status
scales, but AN was associated with lower scores on the
Social Functioning, Vitality, and Physical Functioning
scales than EDNOS. Bamford et al. [15] found lower
Psychological and Physical/Cognitive Scale scores (using
the Eating Disorder Quality of Life [EDQoL] instrument)
in AN than in BN and EDNOS. Latner et al. [21] found that
SF-36 scores were worse in those with subjective bulimic
episodes, food avoidance, laxative abuse, and self-induced
vomiting, and that PCS scores were worse in those with
subjective bulimic episodes and food avoidance. However,
these authors did not find differences in HRQoL between
AN, BN, BED, and EDNOS.
Eight studies investigated the separate and joint effects
of BED and obesity (defined as BMI C30 kg/m2) on
HRQoL [36, 37, 40, 41, 43–46]. The results of Masheb
et al. [43] showed that BED patients with obesity had
significantly lower scores on several SF-36 subscales (i.e.,
Physical Functioning, Bodily Pain, General Health, Vital-
ity, Social Functioning, and PCS) than those without
Fig. 1 The flow diagram of the
systematic literature search
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obesity (the PCS mean [SD] scores in patients with BMI
C30 kg/m2 and BMI\30 kg/m2 were: 45.3 [9.6] vs. 53.6
[9.4], respectively, P = 0.001). Among obese individuals,
all but two studies [41, 45] concluded that BED patients
had significantly reduced HRQoL compared with individ-
uals without BED [36, 37, 46], even in a population with
extreme obesity (defined as BMI C40 kg/m2) [40] (Online
Resource 3). Perez et al. [44] found that obesity was more
strongly related to physical HRQoL variables, but BED
was more predictive of the mental health and social func-
tioning HRQoL variables. In contrast, Ricca et al. [45] did
not find any significant differences in HRQoL between
those obese patients without BED, those with threshold,
and those with subthreshold BED (defined by a minimum
average binge eating [BE] frequency of once a month for a
minimum duration of 6 consecutive months). In the study
conducted by Kolotkin et al. [41], BED was shown to be
associated with more impaired HRQoL in obese individu-
als (the IWQOL mean (SD) total scores in the BED and
non-BED patients were: 51.5 (21.9) vs. 65.3 (19.8),
respectively, P\ 0.001), but BED did not prove to be an
independent factor of weight-related quality of life after
controlling for BMI, demographic variables, and psycho-
logical variables.
The HRQoL burden of EDs is determined not only by
the deficit in HRQoL of the patients themselves, but also
by the potential deficit of close relatives who live with the
patient or caregivers and take care of an ED patient. A
study found that 80 % of the siblings of adolescent ED
patients reported that their HRQoL was negatively affected
by the onset of their siblings’ ED [49]. De La Rie et al. [50]
showed that the caregivers of ED patients had worse
HRQoL than normal controls (mean SF-36 scale scores:
56.2 [Vitality] to 90.4 [Physical Functioning] vs. 68.6
[Vitality] to 84.0 [Social Functioning], respectively). The
caregivers’ perceived burden improved significantly over
the first year of follow-up, but no further improvement was
observed with longer follow-up [51]. Many factors were
associated with higher caregiver burden, such as higher
anxiety and depression, purgative behaviors, lower patient
HRQoL [52], and low-level education [53].
Economic burden
Twenty studies reported data on healthcare utilization: 14
for AN [3, 54–66], 12 for BN [2, 3, 34, 54, 58–62, 64–67],
and 8 for BED [2, 3, 39, 59, 65, 66, 68, 69]. The healthcare
utilization data extracted from the included studies are
provided in Online Resource 4.
AN (78 %), BN (88 %), and BED (73 %) were associ-
ated with increased health service use (for any treatment,
lifetime) compared with individuals without an eating
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Moore et al. [69], the number of 12-month total health
service days (i.e., inpatient care, outpatient care, and
emergency care) of BED patients (11.8–21.4) was higher
than in the healthy comparison group (3.4–8.4), but it was
similar to the utilization found in other major psychiatric
disorders (6.9–18.4). The health service use in AN was
reported to be equal to or higher than in BN or BED [3, 54,
58–62, 64, 65]. The difference in healthcare utilization
between the AN and BN patients was largest in the case of
hospitalization. The length of hospital stay was found to be
much longer for patients with AN (15.0–52.7 days) than
for those with BN (9.0–45.7 days) [54, 58, 60, 61, 64].
Only one study evaluated the effect of obesity (defined
as BMI C30 kg/m2) on health service use in patients with
BED. In the study by Striegel-Moore et al. [69], the number
of 12-month total health service days (i.e., inpatient care,
outpatient care, and emergency care) was found to be
higher for obese BED women (mean [SD] total service
days: 21.4 [28.1]) than for nonobese BED women (mean
[SD] total service days: 11.8 [21.8]); however, the associ-
ation between obesity and health service use was not
significant.
In the assessed studies, patients with AN, BN, or BED
rarely received treatment for their ED, but received more
frequent treatment for comorbid psychiatric symptoms and/
or weight loss [2, 3, 59, 66]. In the study conducted by
Mond et al. [59] on AN, BN, and BED, 22, 14, and 23 % of
the patients, respectively, were treated by a mental health
professional, specifically for their ED in their lifetime.
Data on healthcare costs were reported in 17 studies: 9
for AN [58, 60, 61, 70–75], 11 for BN [31, 34, 58, 60, 61,
73, 75–79], and 2 for BED [39, 68]. In the reviewed
studies, the annual healthcare costs for AN, BN, and BED
ranged from €2993 [61] to €55,270 [71], €888 [78] to
€18,823 [79], and €1762 [39] to €2902 [68], respectively
(Table 2). Detailed information on the reported healthcare
costs is presented in Online Resource 5.
The healthcare costs of AN, BN, and BED were not
compared in any of the included studies. However, 5
studies contrasted AN with BN [58, 60, 61, 73, 75] (Online
Resource 2). In most of these studies, AN was found to be
associated with considerably higher annual healthcare costs
than BN (€5952 vs. €1460 [58], €18,587 vs. €11,406 [60],
and €5445 vs. €3386 [73]). However, Mitchel et al. [75]
estimated higher costs for BN (€6279) than AN (€3221).
Striegel-Moore et al. [61] assessed the cost of EDs (i.e.,
AN, BN, and EDNOS) and compared these costs with the
costs of other mental disorders (i.e., obsessive–compulsive
disorder and schizophrenia). AN (€6590 for female, €2993
for male) and BN (€3229 for female, €4235 for male)
patients had higher costs than obsessive–compulsive dis-
order patients (€2104 for female, €1965 for male) [61]. The
healthcare costs for men with AN and BN were slightly
less than the costs for men with schizophrenia (€5552);
however, the costs were higher for women with
schizophrenia compared to BN (€5259). The healthcare
costs for patients with BN were comparable to the costs
associated with the treatment of EDNOS (female €3229,
male €4235 vs. female €3496, male €2360 [61], and €6279
vs. €6514 [75]). In one of the two studies that examined the
costs of BED, the annual healthcare cost of overweight/
obese BED women (€1,762) was reported to be 36.5 %
higher than that of the age- and sex-matched national
average [39]. Grenon et al. [39] found no association with
BMI (after controlling for age) and the total healthcare
costs in BED. However, this finding is in contrast to the
study by Dickerson et al. [68] that showed a significant
association with higher BMI and higher mental health
medication and total medication costs in women with BED
or recurrent BE.
In AN, premature death in the young patient population
leads to significant indirect costs to society (63 % of the
overall costs), mainly due to the loss of production [58].
Symptom-related costs for food are considerable expense
factors for patients with BN. Crow et al. [76] found that
costs associated with BE and purging in BN accounted for
32.7 % of the total food costs; the mean total annual food
cost per BN patient was €4735. No study was identified for
BED-related food costs.
Discussion
A comprehensive review on the differences in the HRQoL
and economic impact of AN, BN, and BED was missing
from the literature. We analyzed 69 studies: data on
HRQoL were reported in 41 studies (18 for AN, 17 for BN,
and 18 for BED), on healthcare utilization in 20 studies (14
for AN, 12 for BN, and 8 for BED), and on healthcare costs
in 17 studies (9 for AN, 11 for BN, and 2 for BED).
Generally, AN, BN, or BED was associated with sig-
nificantly impaired HRQoL compared with the healthy
population [18, 34, 37, 39, 40, 43]. Evidence also sug-
gests that patients with EDs have impaired HRQoL
compared to those with other psychiatric conditions [80].
Studies showed that obesity was associated with further
deterioration of HRQoL of patients with BED [36, 37, 40,
43, 46]. In addition, other psychopathology factors (e.g.,
depression and anxiety) were associated with lower
HRQoL of patients with AN, BN, and BED [19, 21, 24,
39, 43]. AN, BN, and BED may have differential effects
on HRQoL compared with each other, depending mainly,
but not exclusively, on the study design and the HRQoL
domains investigated [15, 17, 22, 27]. The reviewed
studies provided a range of results, at least partially due
to the heterogeneity in the patient population and the
358 Eat Weight Disord (2016) 21:353–364
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Table 2 Annual cost per patient data on AN, BN, and BED
First author Perspective Country Annual cost per patient in 2014 EUR
AN
Byford [70] Payer UK Inpatient care €23,607
Specialist outpatient care €18,280
General outpatient care €27,889
Included cost categories: inpatient nights, outpatient appointments, day patient contacts,
accident and emergency contacts, state day school, independent day school, independent
boarding school, hospital school, home tuition, school counselor, education welfare officer,
general practitioner, practice nurse, dietician, district nurse, health visitor, community
pediatrician, community psychiatric nurse, clinical psychologist, counselor, family therapist,
dentist, school doctor, school nurse, social worker, eating disorders association, family
therapy, foster care
Crow [71] Payer USA Usual care €16,785
Adequate care €55,270
Included cost categories: inpatient treatment, partial hospitalization, psychotherapy,
medication management, fluoxetine
Haas [72] Hospital Germany €4,900
Included cost categories: physicians, nursing, psychotherapists, dietician, art and music
therapy, psychotherapy, drugs, medical products, services on demand, overhead costs
(medical/non-medical infrastructure)
Haas [73] Hospital Germany €5,445
Included cost categories: physicians, nursing, psychotherapists, dietician, art and music
therapy, psychotherapy, drugs, medical products, services on demand, overhead costs
(medical/non-medical infrastructure)
Krauth [58] Societal Germany €5,952
Included cost categories: inpatient treatment, convalescence statutory health insurance,
rehabilitation statutory pension insurance, inability to work, death
Lock [74] Payer USA €30,700
Included cost categories: medical hospital, outpatient family therapy, medication visit,
medication, doctor visit
Mitchell [75] Payer USA €3,221
Included cost categories: hospital care, healthcare provider, prescription medication
O’Brien [60] Payer USA €18,587
Included cost categories: inpatient cost
Striegel-Moore [61] Payer USA Female €6,590
Male €2,993
Included cost categories: inpatient treatment, outpatient treatment
BN
Crow [77] Societal USA Face-to-face cognitive behavioral therapy €2423
Telemedicine cognitive behavioral therapy €1488
Included cost categories: evaluation and laboratory, cognitive behavioral therapy, subject
travel, gasoline, therapist travel
Crow [76] Patient USA Total food cost €4,735
Binge/purge food cost €1,357
Objective binge eating food cost €668
Diet/laxative/diet pill cost €201
Crow [31] Payer USA Cognitive behavioral therapy €3294
Stepped care €2824
Included cost categories: cognitive behavioral therapy, self-help, medication, physician visit,
emergency room, hospitalization, individual therapy, group therapy, medication management
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research design. Consequently, the study results and
conclusions seemed to be quite heterogeneous. It is dif-
ficult to draw a consistent conclusion on the relative
effects of the assessed EDs on HRQoL, which may be
because AN, BN, and BED share certain psychopathology
symptoms (e.g., loss of control of eating appears both in
BN and BED). In a recently published meta-analysis,
Winkler et al. [81] could also not identify any specific
differences between the HRQoL effects of different ED
diagnostic groups. The HRQoL of the siblings and care-
givers of AN, BN, and BED patients was also found to be
impaired [49–53].
The economic impacts of EDs has been receiving
increasing research attention in recent years [82–84];
however, a comparative review on the economic burden of
AN, BN, and BED was lacking in the literature. Based on
the reviewed studies, AN, BN, and BED are associated
with increased healthcare utilization and higher healthcare
costs. The evaluated EDs are associated with a high rate of
hospitalization, outpatient care, and emergency department
visits [3, 54, 58–62, 64–66, 69]. However, inpatient care
seems to be more common in AN [54, 58, 60, 61, 64],
which could primarily be due the severity of the condition.
It was also notable that patients rarely receive specific
Table 2 continued
First author Perspective Country Annual cost per patient in 2014 EUR





Cost was calculated by multiplying the clinic’s professional fees by the number of visits and
adding the cost of the patient’s expected medication and serum desipramine level
Krauth [58] Societal Germany €1460
Included cost categories: inpatient treatment, convalescence statutory health insurance,
rehabilitation statutory pension insurance, inability to work, death
Haas [73] Hospital Germany €3386
Included cost categories: physicians, nursing, psychotherapists, dietician, art and music
therapy, psychotherapy, drugs, medical products, services on demand, overhead costs
(medical/non-medical infrastructure)
Mitchell [75] Payer USA €6279
Included cost categories: hospital care, healthcare provider, prescription medication
O’Brien [60] Payer USA €11,406
Included cost categories: inpatient care
Pohjolainen [34] Payer Finland €7756
Included cost categories: inpatient care, outpatient care, laboratory cost, radiology cost
Striegel-Moore [61] Payer USA Female €3229
Male €4235
Included cost categories: inpatient treatment, outpatient treatment
Wang [79] Payer USA €18,823
Included cost categories: school-based obesity prevention program
BED
Dickerson [68] Payer USA BED €2902
Recurrent binge eating €3137
Included cost categories: weight- and eating disorder-related services, non-weight- and eating
disorder-related mental health services, other provider-based services, medication services
Grenon [39] Payer Canada €1762
Included cost categories: family physician visits, medication use, diagnostic tests, health
professionals’ visits, specialist visits, herbal remedies, other resources, outpatient visits,
emergency department visits, and inpatient visits
AN anorexia nervosa, BED binge eating disorder, BN bulimia nervosa, EUR euro
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treatment for their ED and mostly received treatment for
general mental health, comorbid psychiatric symptoms,
and/or weight loss [2, 3, 59, 66]. Improvement in diagnosis,
reporting/coding and management of AN, BN, and BED
may improve treatment for these patients.
The cost estimates varied considerably for AN, BN, and
BED, as well as within particular disorders. Several dif-
ferences in the design and analysis of the cost of illness in
the studies reduced the comparability of the cost data. The
annual direct healthcare costs of AN and BN appeared to
be similar to those of other major psychiatric conditions
[61]. Compared with BN, AN was associated with higher
healthcare costs in most assessed studies [58, 60, 72].
Healthcare cost data showed variation across countries;
however, an investigation of the factors behind the cross-
country differences was beyond the scope of this review
(differences in treatment patterns and evaluated cost factors
as well as national characteristics of the healthcare systems
are likely to be key determinants).
Compared to BN, obesity appears to be more common in
BED [2]. Due to the limited number of studies, it is not pos-
sible to definitively separate burden specific to BED from
those associated with obesity. Namely, a higher level of BMI
decreases the physical HRQoL of individuals (e.g., worst
physical functioning) [85]. Nevertheless, BED is distinct
from obesity; there is a unique psychopathology and medical
risk profile associated with BED [86]. Patients with BED have
greater functional impairment, lower HRQoL, and more
subjective distress compared to weight-matched obese indi-
viduals without BED [36, 37, 40, 44, 46]. This suggests that at
least part of the burden of BED is unique to the disorder and
provides a rationale for not only treating weight issues, but the
disorder itself to fully address the burden of BED. However,
obesity may have severe health consequences over time (e.g.,
diabetes and hypertension), which may have an impact on the
long-term burden of BED. Although BED is the most
prevalent ED, there is scarcity of information on the economic
burden of BED; those studies that do report the economic
burden of BED, most reported it in combination with BN or
overall EDs (only 2 studies reported healthcare cost data for
BED [39, 68]). Further research is needed on this topic,
because data on the long-term health and economic impact of
BED are essential to better establish the burden of illness in
this patient population.
Our findings should be considered in light of the fol-
lowing limitations. The current systematic literature review
involved searching only studies that were published in
English and indexed in the selected databases. Despite the
broad database selection, the inclusion of unpublished
material and studies from other resources was precluded.
As a further effort, we screened the references of the
included articles for additional eligible studies. No formal
quality assessment of the identified publications was
performed, because of the large heterogeneity in the study
types of the included studies.
In summary, AN, BN, and BED markedly impair
HRQoL and are associated with increased healthcare use
and costs compared with healthy individuals. The HRQoL
impairment of AN, BN, and BED patients was found to be
similar; however, healthcare utilization (especially, inpa-
tient care) and costs were reported to be higher for AN
patients than for BN and BED patients. Compared to BN,
obesity appears to be more common in patients with BED,
which may contribute to significant impairment of their
HRQoL and higher healthcare use, especially in the long
term. Thus, the burden of BED should be examined sepa-
rately from that of BN. The limited evidence indicates that
further research is warranted to better understand the dif-
ferences between the HRQoL and economic burdens of
BED in contrast to AN and BN in the long term.
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